Correlation Between Acute Gastrointestinal Injury and Venous Return in Critical Ill Patients
Launched by PEKING UNION MEDICAL COLLEGE HOSPITAL · Oct 30, 2024
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating how changes in blood flow to the intestines might affect patients with acute gastrointestinal injury who are critically ill. Researchers want to understand if monitoring the return of blood from the abdomen can help detect problems in the intestines earlier, allowing for better treatment. The study is innovative because it explores a connection that hasn't been thoroughly researched before.
To be eligible for this trial, participants must be between 18 and 80 years old, have sepsis (a severe infection) with an expected stay in the Intensive Care Unit (ICU) of more than three days, and meet certain health criteria. If you join the study, you can expect to undergo some additional monitoring to assess your intestinal blood flow. The goal is to improve how we recognize and treat intestinal issues in critically ill patients, which could lead to better outcomes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients with sepsis with an expected ICU stay of more than 3 days.
- • 2. ≥18 years of age and \<80 years of age.
- Exclusion Criteria:
- • 1. Severe mesenteric or abdominal artery stenosis;
- • 2. Fixed body (such as recent spinal surgery or intracranial hypertension);
- • 3. Patients with contraindications for IAP measurement (such as patients who have recently undergone bladder surgery, been injured, or become pregnant)
- • 4. Having undergone abdominal surgery or chest lowering involving the intestines patients undergoing aortic surgery;
- • 5. Poor quality of abdominal ultrasound images;
- • 6. Hydrothorax or ascites.
About Peking Union Medical College Hospital
Peking Union Medical College Hospital (PUMCH) is a prestigious medical institution and a leading research facility located in Beijing, China. Affiliated with the Chinese Academy of Medical Sciences, PUMCH is renowned for its commitment to advancing healthcare through innovative clinical research and high-quality patient care. The hospital plays a pivotal role in the development and execution of clinical trials across various medical disciplines, focusing on improving treatment outcomes and enhancing medical knowledge. With a multidisciplinary team of experts and state-of-the-art facilities, PUMCH is dedicated to contributing to global health advancements and fostering collaborations in the medical research community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported